Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Research » Trials

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Lyrica Significantly Reduced Peripheral Nerve Pain
Posted: Wednesday, May 20, 2009
Patients suffering from post-traumatic peripheral nerve pain treated with Lyrica® (pregabalin) capsules CV experienced significantly reduced pain compared to those taking placebo, according to new data.

CHMP Recommends Approval of Novo Nordisk's Victoza(R) (Liraglutide) for Type 2 Diabetes
Posted: Wednesday, May 20, 2009
Novo Nordisk announces that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMEA) adopted a positive opinion, recommending marketing authorization, for Victoza® for the treatment of Type 2 diabetes.

Basal-Bolus Injection vs. Basal-Bolus Insulin Pump in Type 1s
Posted: Wednesday, May 20, 2009
To compare injects by syringe and using an insulin pump a randomized open parallel multicenter study was done.

Australian Docs Discover a Type 1 Diabetes Breakthrough
Posted: Tuesday, May 12, 2009
Australian doctors believe they have found the key to eradicating Type 1 diabetes, the kind that obliges sufferers to regulate their blood glucose levels every day of their lives.

Lacosamide Safely Reduces Pain of Diabetic Neuropathy
Posted: Tuesday, May 12, 2009
The antiepileptic drug lacosamide is effective in reducing painful diabetic neuropathy without serious side effects, according to results from two phase 3 trials, one in the United States and one in the European Union, researchers reported at the American Academy of Neurology (AAN) 61st Annual Meeting.

Antibiotic Use in Childhood Not Linked to Type 1 Diabetes
Posted: Tuesday, May 12, 2009
Contrary to what several other studies have shown, the results of a nationwide study of Danish children suggest that antibiotic use does not affect the development of Type 1 diabetes.

Once a Year Byetta in the Diabetes Pipeline
Posted: Wednesday, May 06, 2009
With Lilly/Amylin's submission of their once a week Byetta, another company, Intarcia Therapeutics, Inc., announces completion of enrollment of ITCA 650 phase 1b study for the treatment of Type 2 diabetes with their once a year dosing of Byetta.

Intranasal Insulin Improves Diabetic Neuropathy
Posted: Wednesday, April 29, 2009
Intranasal insulin slows the progression of diabetic peripheral neuropathy. Peak blood concentrations of insulin were nearly 1000-fold lower after intranasal delivery than after subcutaneous delivery.

Transplants Help Type 1 Diabetics Stop Insulin Injections
Posted: Wednesday, April 29, 2009
People with Type 1 diabetes who received stem cell transplants from their own cells were able to go as long as four years without needing insulin treatments, U.S. researchers reported.

Liraglutide Has Low CVD Risk but May Be Blocked for Approval
Posted: Wednesday, April 15, 2009
Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of animal studies linking the injection to thyroid cancer.

Page 14 of 23
 |<   <<   <  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement